drugset / Trial / NCT03034941

Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients

NCT03034941

Phase 4 Completed 35 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study was to evaluate the impact of short-term weight reduction achieved with 12-week intervention with metformin alone or in combination with liraglutide on oocyte maturity and embryo quality in infertile obese PCOS population.

Timeline

Start
2014-04
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Liraglutide Peptide 1.2 mg Subcutaneous
Comparator Metformin Small molecule 1000 mg Oral